Augmentation of recombinant fibronectin polypeptide CH50 on the antitumor function of macrophages

Abstract

We prepared an anti-metastatic polypeptide, recombinant fibronectin polypeptide CH50, and finished the preliminary identification of its functions. In this paper, we studied the effect of this polypeptide on the function of macrophages. CH50 can significantly augment the production of nitric oxide (NO) by macrophages in a dose-dependent manner. The continuous presence of CH50 had a much stronger effect. In the presence of CH50, the cytotoxicity of macrophages to melanoma B16/F1 cells was significantly enhanced, and a stronger effect was obtained if CH50 was present continuously. CH50 polypeptide and IFN-γ have a synergistic effect on the production of NO by macrophages and the cytotoxicity of macrophages on tumor cells. In thein vivo experiments, CH50 can inhibit the growth of tumor cells, and have a better effect in the presence of IFN-7. Our results suggest that recombinant fibronectin polypeptide CH50 has two functions: one is to inhibit the metastasis of tumor cells, and the other one is to augment the function of macrophages. And this polypeptide will be potentially useful in tumor therapy.

Keywords

fibronectin / recombinant polypeptide / macrophage / cytotoxicity

References

[1] HynesR O. Fibronectins, 1990NEW YorkSpringer-Verlag New York Inc

[2] BeezholdD H, PersoniusC. Fibronectin fragments stimulate tumor necrosis factor secretion by human monocytes. J Leukoc Biol, 1992, 51: 59-59

[3] ChangZ L, BeezholdD H, PersoniusC D, et al.. Fibronectin cell-binding domain triggered transmembrane signal transduction in human monocytes. J Leukoc Biol, 1993, 53: 79-79

[4] DohertyD E, HensonP M, ClarkR A. Fibronectin fragments containing the RGDS cellbinding domain mediate monocyte migration into the rabbit lung. A potential mechanism for C5 fragment-induced monocyte lung accumulation. J Clin Invest, 1990, 86: 1065-1065

[5] FengZ H, ZhangG M, LiD, et al.. Construction of expressing plasmids of recombinant FN polypeptides with bifunctional-domain and the characterization of the products expressed in E. coli. J Tongji Med Univ, 1996, 16(2): 70-70

[6] SaikiI, MurataJ, MakabeT, et al.. Inhibition of lung metastasis by synthetic and recombinant fragments of human fibronectin with functional domains. Jpn J Cancer Res, 1990, 81: 1003-1003

[7] SaikiI, MatsumotoY, MurataJ, et al.. Recombinant fusion polypeptide with Cell- and Hep-arin-binding domains of fibronectin inhibits liver metastasis of L5178Y-ML25 lymphoma cells. Jpn J Cancer Res, 1991, 82: 1120-1120

[8] DingA H, NathanC F, StuehrD J. Release of reactive nitroge intermediated and reactive oxygen intermetiates from mouse peritoneal macrophages. J Immunol, 1988, 141: 2407-2407

[9] SambrookJ, FritschE F, ManiatisT. Molecular Cloning: a laboratory manual, 1989New YorkCold Spring Harbor Laboratory Press30-39

[10] JunC D, YoonH J, KimH M, et al.. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma. Biochem Biophys Res Commun, 1995, 206: 969-969

[11] ShakibaeiM, ZimmermannB, SchellerM. Endocytosis of integrin alpha 5 beta 1 (fibronectin receptor) of mouse peritoneal macrophages in vitro: an immunoelectron microscopic study. J Strut Biol, 1993, 111: 180-180

[12] MaruguchiY, TodaK, WatanabeY, et al.. Modulatory effects of interferon-gamma on the fibronectin receptor function of squamous cell carcinoma cells in vitro. J Dermatol Sci, 1991, 2: 422-422